HMGN - Hemagen Diagnostics Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5131.75k
Enterprise Value 35.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.03
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.26
Enterprise Value/EBITDA 6-18.61

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2012
Most Recent Quarter (mrq)Sep 30, 2012


Profit Margin -22.45%
Operating Margin (ttm)-10.83%

Management Effectiveness

Return on Assets (ttm)-10.27%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.04M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-23.60%
Gross Profit (ttm)1.61M
EBITDA -273.66k
Net Income Avi to Common (ttm)-907.32k
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.29k
Total Cash Per Share (mrq)0
Total Debt (mrq)5.03M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.07
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)-358.69k
Levered Free Cash Flow (ttm)-115.85k

Trading Information

Stock Price History

Beta 0.53
52-Week Change 3-15.00%
S&P500 52-Week Change 323.26%
52 Week High 30.0700
52 Week Low 30.0000
50-Day Moving Average 30.0100
200-Day Moving Average 30.0117

Share Statistics

Avg Vol (3 month) 37.42k
Avg Vol (10 day) 32.16k
Shares Outstanding 515.5M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 30
Short % of Float 30.00%
Shares Short (prior month) 31.4k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A